Newsletter February 2024

Newsletter February 2024

FOREWORD BY PD DR. DR. FRANÇOIS MAJO

TOPICS:

  • Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes
  • Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
  • Smart Contact Lenses respond to UV and Temperature Changes
  • Medicines & Healthcare products Regulatory Agency (UK) and FDA (USA) approves first CRISPR gene therapy for sickle cell anemia and betathalassemia
  • Rates of infectious keratitis and other ocular surface adverse events in corneal cross-linking for keratoconus and corneal ectasias performed in an office-based setting: a retrospective cohort study
No Comments

Sorry, the comment form is closed at this time.